Churchill Capital Corp Xi Cl A (CCXI)
Churchill Capital Corp Xi Cl A (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCXI | RLAY | ELVN | ||
| Company | Churchill Capital Corp Xi Cl A | Relay Therapeutics Inc | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.56 | 20.70 | 51.64 | ||
| High | 17.40 | 20.75 | 51.76 | ||
| Low | 15.25 | 19.31 | 49.51 | ||
| Latest | 15.55 | 20.00 | 51.09 | ||
| Change | -0.68 | -0.75 | -1.09 | ||
| % Change | -4.19% | -3.59% | -2.09% | ||
| Volume | 2,986,400 | 3,188,200 | 623,600 | ||
| 20-Day Average Volume | 4,300,810 | 4,631,220 | 2,469,495 | ||
| Previous Close | 16.23 | 20.75 | 52.18 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.54 | 17.68 | 47.90 | ||
| 20-Day Raw Stochastic | 56.38% | 89.33% | 90.29% | ||
| 20-Day Relative Strength | 62.47 | 65.57 | 62.58 | ||
| Weighted Alpha | N/A | +421.32 | +55.01 | ||
| Today's Opinion | N/A | 100% Buy | 100% Buy | ||
| Previous Opinion | N/A | 100% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -18.59% since 07/02/26 | +7.27% since 07/02/26 | +2.55% since 07/02/26 | ||
| Low | 15.16 on 07/08/26 | 18.34 on 07/06/26 | 48.52 on 07/08/26 | ||
| High | 19.69 on 07/06/26 | 20.79 on 07/09/26 | 52.38 on 07/07/26 | ||
| 1-Month | |||||
| %Chg | +51.12% since 06/08/26 | +48.30% since 06/10/26 | +38.08% since 06/10/26 | ||
| Low | 10.20 on 06/16/26 | 13.44 on 06/11/26 | 39.00 on 06/12/26 | ||
| High | 19.69 on 07/06/26 | 20.79 on 07/09/26 | 52.39 on 06/30/26 | ||
| 3-Month | |||||
| %Chg | +52.45% since 04/10/26 | +33.90% since 04/10/26 | +12.73% since 04/10/26 | ||
| Low | 10.14 on 05/14/26 | 11.62 on 05/20/26 | 33.45 on 06/08/26 | ||
| High | 19.69 on 07/06/26 | 20.79 on 07/09/26 | 52.39 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/09/26 | +150.38% since 01/09/26 | +96.50% since 01/09/26 | ||
| Low | 10.07 on 02/09/26 | 7.01 on 01/20/26 | 23.25 on 01/12/26 | ||
| High | 19.69 on 07/06/26 | 20.79 on 07/09/26 | 52.39 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 3,832,678 | 3,111,636 | ||
| Shares Outstanding, K | 71,356 | 191,586 | 60,905 | ||
| Annual Sales | 32,220,000 | 15,360,000 | 0 | ||
| Annual Net Income | -131,760,000 | -276,480,000 | -103,690,000 | ||
| Last Quarter Sales | 11,760,000 | 3,000,000 | 0 | ||
| Last Quarter Net Income | -31,650,000 | -73,290,000 | -23,630,000 | ||
| 60-Month Beta | 1.22 | 1.67 | 0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.41 on 05/05/26 | -0.38 on 05/07/26 | ||
| Earnings Date | 11/08/22 | 08/06/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||